Biosimilar Newsletter Archive
-
03.20.25 -- Discover How To Optimize Productivity In Your mAb Capture
3/20/2025
03/20/25 Biosimilar Development Newsletter
-
03.20.25 -- Comparison Of WFI Production Methods
3/20/2025
03/20/25 Biosimilar Development Newsletter
-
03.13.25 -- Optimize Your High Concentration Biologic Production Process
3/13/2025
03/13/25 Biosimilar Development Newsletter
-
03.13.25 -- Emerging Trends In mAbs Manufacturing
3/13/2025
03/13/25 Biosimilar Development Newsletter
-
03.06.25 -- Clinical Regulatory Changes One of Many Tailwinds for Biosimilars
3/6/2025
03/06/25 Biosimilar Development Newsletter
-
02.27.25 -- A New Approach For Minimizing Human Errors In Biopharmaceuticals
2/27/2025
02/27/25 Biosimilar Development Newsletter
-
02.20.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline
2/20/2025
02/20/25 Biosimilar Development Newsletter
-
02.13.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline
2/13/2025
02/13/25 Biosimilar Development Newsletter
-
02.06.25 -- Developing ADCs? A Refresher On HPAPI Occupational Health Risk Mitigation
2/6/2025
02/06/25 Biosimilar Development Newsletter
-
01.30.25 -- New Regulatory Survey Findings: Biotech Market Access Challenges
1/30/2025
01/30/25 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more